These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 11465391

  • 1. Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline.
    Murray S, Odupitan AO, Murray BP, Boobis AR, Edwards RJ.
    Xenobiotica; 2001 Mar; 31(3):135-51. PubMed ID: 11465391
    [Abstract] [Full Text] [Related]

  • 2. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
    Ball SE, Ahern D, Scatina J, Kao J.
    Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
    [Abstract] [Full Text] [Related]

  • 3. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
    Wen X, Wang JS, Backman JT, Kivistö KT, Neuvonen PJ.
    Drug Metab Dispos; 2001 Nov; 29(11):1359-61. PubMed ID: 11602509
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes.
    Nakajima M, Kobayashi K, Oshima K, Shimada N, Tokudome S, Chiba K, Yokoi T.
    Xenobiotica; 1999 Sep; 29(9):885-98. PubMed ID: 10548449
    [Abstract] [Full Text] [Related]

  • 6. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
    Yao HT, Chang YW, Lan SJ, Chen CT, Hsu JT, Yeh TK.
    Life Sci; 2006 Nov 25; 79(26):2432-40. PubMed ID: 16978661
    [Abstract] [Full Text] [Related]

  • 7. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.
    Feierman DE, Lasker JM.
    Drug Metab Dispos; 1996 Sep 25; 24(9):932-9. PubMed ID: 8886601
    [Abstract] [Full Text] [Related]

  • 8. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S, Fujimaki Y, Yokoyama H, Okazaki O, Sudo K.
    Drug Metab Dispos; 2005 Nov 25; 33(11):1628-36. PubMed ID: 16049129
    [Abstract] [Full Text] [Related]

  • 9. Effects of propofol on human hepatic microsomal cytochrome P450 activities.
    McKillop D, Wild MJ, Butters CJ, Simcock C.
    Xenobiotica; 1998 Sep 25; 28(9):845-53. PubMed ID: 9764927
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
    Sahi J, Black CB, Hamilton GA, Zheng X, Jolley S, Rose KA, Gilbert D, LeCluyse EL, Sinz MW.
    Drug Metab Dispos; 2003 Apr 25; 31(4):439-46. PubMed ID: 12642470
    [Abstract] [Full Text] [Related]

  • 12. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA, Tjia JF, Back DJ.
    Br J Clin Pharmacol; 1998 Feb 25; 45(2):107-14. PubMed ID: 9491822
    [Abstract] [Full Text] [Related]

  • 13. Cytochrome P-450 enzymes and FMO3 contribute to the disposition of the antipsychotic drug perazine in vitro.
    Störmer E, Brockmöller J, Roots I, Schmider J.
    Psychopharmacology (Berl); 2000 Sep 25; 151(4):312-20. PubMed ID: 11026737
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase.
    Grimm SW, Dyroff MC.
    Drug Metab Dispos; 1997 May 25; 25(5):598-602. PubMed ID: 9152599
    [Abstract] [Full Text] [Related]

  • 15. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes.
    Yeung JH, Or PM.
    Phytomedicine; 2012 Mar 15; 19(5):457-63. PubMed ID: 22305191
    [Abstract] [Full Text] [Related]

  • 16. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.
    Venkatakrishnan K, von Moltke LL, Duan SX, Fleishaker JC, Shader RI, Greenblatt DJ.
    J Pharm Pharmacol; 1998 Mar 15; 50(3):265-74. PubMed ID: 9600717
    [Abstract] [Full Text] [Related]

  • 17. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.
    Frye RF, Branch RA.
    Br J Clin Pharmacol; 2002 Feb 15; 53(2):155-62. PubMed ID: 11851639
    [Abstract] [Full Text] [Related]

  • 18. Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes.
    Kobayashi K, Nakajima M, Oshima K, Shimada N, Yokoi T, Chiba K.
    Drug Metab Dispos; 1999 Aug 15; 27(8):860-5. PubMed ID: 10421611
    [Abstract] [Full Text] [Related]

  • 19. Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.
    Lim HK, Duczak N, Brougham L, Elliot M, Patel K, Chan K.
    Drug Metab Dispos; 2005 Aug 15; 33(8):1211-9. PubMed ID: 15860655
    [Abstract] [Full Text] [Related]

  • 20. CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitor.
    Venkatakrishnan K, von Moltke LL, Greenblatt DJ.
    Drug Metab Dispos; 1999 Dec 15; 27(12):1519-22. PubMed ID: 10627170
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.